HomeSGMT • NASDAQ
add
Sagimet Biosciences Inc
Previous close
$7.08
Day range
$6.99 - $7.29
Year range
$1.73 - $11.41
Market cap
234.81M USD
Avg Volume
560.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.33M | -15.19% |
Net income | -12.91M | 11.70% |
Net profit margin | — | — |
Earnings per share | -0.40 | 11.11% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 116.69M | -23.47% |
Total assets | 128.40M | -26.53% |
Total liabilities | 9.15M | 123.51% |
Total equity | 119.26M | — |
Shares outstanding | 32.52M | — |
Price to book | 1.93 | — |
Return on assets | -26.96% | — |
Return on capital | -28.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -12.91M | 11.70% |
Cash from operations | -10.18M | 47.98% |
Cash from investing | 75.00K | -87.98% |
Cash from financing | 274.00K | — |
Net change in cash | -9.83M | 48.11% |
Free cash flow | -6.33M | 57.62% |
About
Founded
2006
Headquarters
Website
Employees
14
